l9n/ Pennsylvania

2019–2020 Regular Session

House Bill 137

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose response immunity.

Did not become law. It stopped in the Senate's Judiciary Committee on December 26, 2019. The 2019–2020 session has ended.

Sponsors

Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.

Its course

January 28 to December 26, 2019, on one scale. In the top row each mark is a day something happened; taller marks are busier days.

Each committee stop sits inside its chamber.

Every action13 actions on 7 days

In the House of RepresentativesJan 28 to Dec 17323 days

JudiciaryJan 28 to Oct 22267 days

AppropriationsNov 21 to Dec 1625 days

In the SenateDec 17 to Dec 26 · stopped9 days

JudiciaryDec 26 to Dec 26 · stopped0 days

Votes

Yeas to nays, as the General Assembly recorded them. Committee votes are set in.

  • House of Representatives, third reading122–72

    Passed · Dec 17

Amendments

Each amendment offered, and what became of it.

  • House of Representatives committee amendmentAdopted

    Adopted Oct 22

Text

Each version as the General Assembly printed it.

l9n doesn't hold this bill's text yet.

What happened

In l9n's words, one line for each step. Every action as the General Assembly published it is below.

In the House of Representatives Jan 28 – Dec 17

  1. Sent to JUDICIARY
  2. JUDICIARY recommended it as amended
  3. Read a second time
  4. Sent to APPROPRIATIONS
  5. APPROPRIATIONS recommended it
  6. Passed the House of Representatives, 122 to 72

In the Senate Dec 26

  1. Arrived in the Senate
  2. Sent to JUDICIARY
All 13 actions, as published